Skip to main content

The independent medical news service

06-05-2021 | Oncology | News | Article

TAPUR corroborates pembrolizumab benefit in TMB-high metastatic breast cancer

Heavily pretreated patients with metastatic breast cancer characterized by a high tumor mutational burden are likely to derive “meaningful clinical benefit” from pembrolizumab monotherapy, say the TAPUR researchers.

30-04-2021 | Oncology | News | Article

Breast conserving therapy may be an option for BRCA1/2 variant carriers

Individuals with breast cancer and a BRCA1/2 variant experience comparable survival rates whether they are treated with breast-conserving therapy or mastectomy with or without radiotherapy, Chinese researchers suggest.

28-04-2021 | Oncology | News | Article

AHA issues statement on managing hormonal therapy-related CVD risks

The American Heart Association has released a consensus statement on the management of cardiovascular disease in patients receiving hormonal therapies for breast or prostate cancer.

26-04-2021 | Oncology | News | Article

Alisertib addition may benefit metastatic breast cancer patients

Women with hormone receptor-positive, HER2-negative metastatic breast cancer derive a significant progression-free survival benefit from the addition of alisertib to paclitaxel, indicate phase 2 trial findings.

22-04-2021 | Oncology | News | Article

Limited evidence to link antihypertensive use to cancer

An extensive meta-analysis of individual participant data has not found consistent evidence to indicate that antihypertensive use is associated with an increased risk for cancer.

21-04-2021 | Oncology | News | Article

Interventions needed to support mammography attendance among Black women

Black race is a significant predictor of nonadherence to scheduled screening mammography appointments, suggests research.